Skip to content

Patient-engaged Development and Testing of Educational Content on Side Effects of Statins

Patient-engaged Development and Pilot Testing of Educational Content to Improve Understanding of Pharmacological vs Nocebo Effects of Statins

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07094412
Enrollment
30
Registered
2025-07-30
Start date
2025-07-31
Completion date
2026-07-31
Last updated
2025-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Keywords

statin side effects, nocebo effect

Brief summary

The purpose of this study is to learn about people's experiences and perspectives on side effects of statins and to use this information to develop and test educational content to help people understand statin side effects when they are newly prescribed a statin. Participants in the first phase of the study will fill out a survey and participate in a focus group or interview. Participants in the second phase of the study will view educational content, fill out a survey, and participate in two interviews.

Interventions

OTHEREducational content on statin side effects

Participants will view educational content that will include written material, graphics and video. The content will explain side effects and benefits of statin medications. The content will also explain placebo and nocebo effects and how they may impact people taking statins.

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has at least one cardiovascular risk factor, including diabetes (DM), hypertension (HTN), hyperlipidemia (HLD), or a 10-year risk of atherosclerotic cardiovascular disease (ASCVD) of equal to or greater than 7.5% * Able to speak and read English

Exclusion criteria

* Established diagnosis of atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease (CAD), peripheral arterial disease (PAD), or history of stroke * Unable to access and engage with web-based education content for any reason (either independently or with the help of a support person) * Is a healthcare professional at the college level or above, defined as a registered nurse, nurse practitioner, physician assistant, physician, dentist, or pharmacist * Has a graduate-level degree of any kind * Hospice or end-of-life

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of educational interventionWithin 1 week of enrollmentNumber of enrolled participants who complete the educational intervention
Acceptability - satisfaction with educational interventionWithin 1 week of exposure to educational contentParticipants are asked to rate their satisfaction with the educational content on a scale of 1-5, ranging from 1-very dissatisfied to 5-very satisfied.
Acceptability - likelihood to recommend educational contentWithin 1 week of exposure to the educational contentParticipants are asked how likely they are to recommend the educational content to friends or family, on a scale of 1 to 5, where 1 corresponds to definitely will not recommend and 5 corresponds to definitely will recommend.

Secondary

MeasureTime frameDescription
Change in knowledge of statin side effects and benefitsAt baseline, within 1 week of exposure to the educational content and again 4-6 weeks laterParticipants will be asked a series of questions (some multiple choice and some open-ended) about statin side effects and benefits. This instrument will be developed by the investigators during the first phase of the study which will utilize focus groups to explore patients experiences and beliefs with regard to statin side effects.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026